In/IN
Silico/NN
Study/NN
of/IN
Human/JJ
Gap/NN
Junction/NN
Beta-2/NN
Protein/NN
by/IN
Homology/NN
Modeling/JJ
./.
====================
Asp66his/DT
,/,
Asp54Lys/NNS
,/,
and/CC
Asp50Asn/NN
are/VBP
mutations/NNS
in/IN
connexin/NN
26/CD
that/DT
are/VBP
observed/VBN
in/IN
the/DT
clinic/NN
and/CC
give/VBP
rise/NN
to/TO
autosomal/JJ
dominant/JJ
syndromes/NNS
./.
====================
They/PRP
are/VBP
the/DT
result/NN
of/IN
point/NN
mutations/NNS
in/IN
the/DT
human/JJ
gap/NN
junction/NN
β2/NN
gene/NN
./.
====================
In/IN
order/NN
to/TO
investigate/VB
the/DT
structural/JJ
mechanism/NN
of/IN
Bart-Pumphrey/NN
Syndrome/NN
,/,
Keratitis-IchthyosisDeafness/NN
Syndrome/NN
,/,
and/CC
Vohwinkel/NN
Syndrome/NN
,/,
homology/NN
modeling/VBG
was/VBD
carried/VBN
out/RP
./.
====================
Asp66/DT
has/VBZ
direct/JJ
contact/NN
with/IN
Asn62/NN
by/IN
two/CD
hydrogen/NN
bonds/NNS
in/IN
the/DT
wildtype/JJ
protein/NN
,/,
and/CC
in/IN
Asp66His/NN
,/,
the/DT
biggest/JJS
change/NN
observed/VBN
is/VBZ
a/DT
tremendous/JJ
energy/NN
increase/VBP
caused/VBD
by/IN
hydrogen/NN
bond/NN
breakage/NN
to/TO
Asn62/NN
./.
====================
Shifts/NNS
in/IN
the/DT
side/JJ
chain/NN
and/CC
new/JJ
hydrogen/NN
bond/NN
formation/NN
are/VBP
observed/VBN
for/IN
Lys54/NN
compared/VBN
to/TO
the/DT
wild-type/JJ
protein/NN
(/(
Asn54/NN
)/)
and/CC
result/NN
in/IN
closer/NN
contact/NN
to/TO
Val84/NN
./.
====================
Asp50Asn/NN
causes/VBZ
a/DT
significant/JJ
decrease/NN
in/IN
bond/NN
energy/NN
,/,
and/CC
residual/JJ
charge/NN
reversal/JJ
repels/VBZ
the/DT
ion/NN
and/CC
metabolites/NNS
and/CC
,/,
hence/RB
,/,
inhibits/VBZ
their/PRP$
transportation/NN
./.
====================
Such/JJ
perturbations/NNS
are/VBP
likely/JJ
to/TO
be/VB
a/DT
factor/NN
contributing/VBG
to/TO
abnormal/JJ
functioning/VBG
of/IN
ion/NN
channels/NNS
,/,
resulting/VBG
cell/NN
death/NN
and/CC
disease/NN
./.
====================
Hearing/VBG
impairment/JJ
or/CC
hearing/JJ
loss/NN
is/VBZ
a/DT
full/JJ
or/CC
partial/JJ
decrease/NN
in/IN
the/DT
ability/NN
to/TO
perceive/JJ
sounds/NNS
,/,
induced/VBD
by/IN
various/JJ
biological/JJ
(/(
Tremblay/NNP
and/CC
Ross/NNP
,/,
2007/CD
)/)
,/,
environmental/JJ
(/(
Eyken/NN
et/FW
al./FW
,/,
2007/CD
)/)
,/,
and/CC
genetic/JJ
factors/NNS
./.
====================
Various/JJ
dominant/JJ
and/CC
recessive/JJ
genes/NNS
subsist/VBP
that/DT
induce/VBP
inherited/VBN
hearing/NN
impairments/NNS
(/(
Laer/NN
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
Kelsell/NN
et/FW
al/JJ
./.
====================
1997/CD
reported/VBD
a/DT
GJB2/NN
mutation/NN
,/,
leading/VBG
to/TO
hearing/JJ
deterioration/NN
./.
====================
The/DT
gap/NN
junction/NN
β2/NN
gene/NN
(/(
GJB2/NN
)/)
is/VBZ
situated/JJ
on/IN
the/DT
long/JJ
arm/NN
(/(
q/RB
arm/NN
)/)
of/IN
human/JJ
chromosome/NN
13/CD
at/IN
a/DT
position/NN
between/IN
11/CD
and/CC
12/CD
(/(
Castillo/NN
et/FW
al./FW
,/,
2005/CD
)/)
./.
====================
The/DT
GJB2/NN
gene/NN
encodes/VBZ
for/IN
the/DT
connexin/NN
protein/NN
(/(
GJB2/NN
protein/NN
)/)
(/(
Cx26/NN
)/)
(/(
Latting/JJ
et/FW
al./FW
,/,
2008/CD
)/)
./.
====================
Gap/RB
junction/NN
β2/NN
protein/NN
,/,
commonly/RB
known/VBN
as/IN
connexin/NN
26/CD
(/(
Cx26/NN
)/)
,/,
belongs/VBZ
to/TO
a/DT
family/NN
of/IN
structurally/RB
related/JJ
transmembrane/JJ
proteins/NNS
that/WDT
mediate/VBP
intracellular/JJ
transport/VBP
of/IN
various/JJ
ions/NNS
and/CC
molecules/NNS
(/(
Sosinsky/NNP
,/,
1995/CD
)/)
./.
====================
Various/JJ
connexin/NN
proteins/NNS
assemble/JJ
with/IN
each/DT
other/JJ
and/CC
form/VBP
gap/NN
junctions/NNS
./.
====================
Gap/NN
junctions/NNS
are/VBP
the/DT
clusters/NNS
of/IN
intercellular/JJ
channels/NNS
involved/VBN
in/IN
direct/JJ
communication/NN
between/IN
cells/NNS
./.
====================
GJB2/NN
mutations/NNS
result/VBP
in/IN
altered/JJ
protein/NN
sequences/NNS
./.
====================
Alterations/NNS
in/IN
the/DT
protein/NN
sequence/NN
are/VBP
the/DT
predominant/JJ
cause/VBP
of/IN
inherited/VBN
,/,
sensorineural/JJ
deafness/NN
(/(
Zelante/NN
et/FW
al./FW
,/,
1997/CD
)/)
./.
====================
Immunohistochemistry/NN
of/IN
inner/JJ
ear/JJ
tissues/NNS
has/VBZ
shown/VBN
that/IN
connexin/NN
26/CD
and/CC
connexin/NN
30/CD
colocalize/VBP
(/(
Forge/JJ
et/FW
al./FW
,/,
2002/CD
;/:
Lautermann/NNP
et/FW
al./FW
,/,
1998/CD
)/)
./.
====================
Connexin/NN
26/CD
has/VBZ
a/DT
structural/JJ
resemblance/NN
to/TO
innexins/NNS
that/DT
form/VBP
gap/NN
junctions/NNS
in/IN
invertebrates/VBZ
but/CC
has/VBZ
quite/RB
a/DT
different/JJ
protein/NN
sequence/NN
./.
====================
The/DT
molecular/JJ
weight/NN
of/IN
connexin/NN
is/VBZ
about/RB
26/CD
KDa/JJ
,/,
a/DT
product/NN
of/IN
the/DT
GJB2/NN
gene/NN
./.
====================
Connexin/NN
exists/VBZ
in/IN
a/DT
dynamic/JJ
cycle/NN
of/IN
synthesis/NN
and/CC
replacement/JJ
because/IN
of/IN
a/DT
short/JJ
life/NN
span/NN
of/IN
a/DT
few/JJ
hours/NNS
(/(
Musil/NN
,/,
et/FW
al./FW
,/,
1993/CD
)/)
./.
====================
Connexin/NN
26/CD
is/VBZ
found/VBN
in/IN
cells/NNS
throughout/IN
the/DT
body/NN
,/,
particularly/RB
in/IN
the/DT
inner/JJ
ear/JJ
and/CC
the/DT
skin/NN
,/,
and/CC
permits/VBZ
the/DT
transport/NN
of/IN
potassium/NN
ions/NNS
and/CC
small/JJ
molecules/NNS
in/IN
neighboring/JJ
cells/NNS
(/(
Castillo/NN
et/FW
al./FW
,/,
2005/CD
)/)
./.
====================
Its/PRP$
presence/NN
in/IN
the/DT
cochlea/NN
is/VBZ
associated/VBN
with/IN
hearing/JJ
./.
====================
GJB2/NN
mutations/NNS
are/VBP
the/DT
cause/JJ
of/IN
recessive/JJ
and/CC
dominant/JJ
forms/NNS
of/IN
deafness/NN
(/(
Laer/NN
et/FW
al./FW
,/,
2001/CD
)/)
,/,
affecting/VBG
1/CD
in/IN
1000/CD
children/NN
(/(
BitnerGlindzicz/NNP
,/,
2002/CD
)/)
./.
====================
About/RB
20/CD
mutations/NNS
of/IN
gap/JJ
junction/NN
β2/NN
have/VBP
been/VBN
described/VBN
as/IN
being/VBG
related/JJ
to/TO
diseases/NNS
(/(
Abe/NNP
et/FW
al./FW
,/,
2000/CD
)/)
and/CC
various/JJ
syndromes/NNS
,/,
such/JJ
as/IN
BartPumphrey/JJ
Syndrome/NN
,/,
Keratitis/NN
IchthyosisDeafness/NN
Syndrome/NN
,/,
and/CC
Vohwinkel/JJ
Syndrome/NN
./.
====================
(/(
Richard/NN
et/FW
al./FW
,/,
2004/CD
;/:
Snoeckx/NNP
et/FW
al./FW
,/,
2005/CD
;/:
Yotsumoto/NN
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
The/DT
mutations/NNS
alter/VBP
the/DT
amino/NN
acid/NN
sequence/NN
of/IN
connexin/NN
26/CD
and/CC
result/NN
in/IN
impaired/JJ
functioning/VBG
of/IN
the/DT
protein/NN
associated/VBN
with/IN
ion/NN
channels/NNS
,/,
especially/RB
./.
====================
In/IN
fact/NN
,/,
a/DT
range/NN
of/IN
phenotypic/JJ
presentations/NNS
of/IN
autosomal/JJ
dominant/JJ
and/CC
recessive/JJ
gap/NN
junction/NN
β2/NN
gene/NN
mutations/NNS
are/VBP
intriguing/JJ
./.
====================
Such/JJ
mutations/NNS
result/VBP
in/IN
an/DT
unstable/JJ
or/CC
malformed/VBN
protein/NN
,/,
unable/JJ
to/TO
form/VB
gap/NN
junctions/NNS
,/,
or/CC
they/PRP
result/VBP
in/IN
a/DT
modified/JJ
protein/NN
that/WDT
builds/VBZ
dysfunctional/JJ
gap/NN
junctions/NNS
./.
====================
So/RB
,/,
the/DT
falsified/VBN
or/CC
modified/VBN
connexin/NN
26/CD
curbs/NNS
the/DT
normal/JJ
arrangement/NN
of/IN
gap/NN
junctions/NNS
and/CC
,/,
hence/RB
,/,
their/PRP$
proper/JJ
functioning/VBG
,/,
affecting/VBG
the/DT
transition/NN
of/IN
sound/JJ
waves/NNS
to/TO
neural/JJ
impulses/VBZ
./.
====================
So/RB
,/,
the/DT
present/JJ
study/NN
was/VBD
carried/VBN
out/RP
to/TO
highlight/VB
the/DT
structural/JJ
changes/NNS
,/,
especially/RB
the/DT
hydrogen/NN
bonding/VBG
,/,
bond/CC
angles/NNS
,/,
bond/CC
length/NN
,/,
force/IN
field/NN
energies/VBZ
,/,
and/CC
PI/NN
values/NNS
,/,
because/IN
such/JJ
forces/IN
and/CC
factors/NNS
are/VBP
considered/VBN
to/TO
be/VB
contributing/VBG
to/TO
the/DT
effect/NN
on/IN
amino/NN
acid/NN
residues/NNS
,/,
their/PRP$
stability/NN
,/,
and/CC
normal/JJ
functioning/VBG
(/(
Karaguller/NNP
et/FW
al./FW
,/,
2004/CD
;/:
Talley/NNP
et/FW
al./FW
,/,
2008/CD
)/)
./.
====================
βThe/DT
X-ray/NN
crystallographic/JJ
structure/NN
of/IN
connexin/NN
26/CD
is/VBZ
not/RB
known/VBN
./.
====================
But/CC
,/,
the/DT
protein/NN
sequence/NN
and/CC
basic/JJ
protein/NN
structure/NN
are/VBP
known/VBN
and/CC
well/RB
characterized/VBN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
Sequence/NN
Analysis/NN
:/:
The/DT
primary/JJ
sequence/NN
of/IN
human/JJ
connexin/NN
26/CD
(/(
primary/JJ
accession/NN
no/DT
./.
====================
P29033/NN
)/)
was/VBD
retrieved/VBN
from/IN
SWISS-Prot/JJ
(/(
Bairoch/NN
and/CC
Apweiler/NN
,/,
1997/CD
)/)
./.
====================
Using/VBG
in/FW
silico/NN
tools/NNS
,/,
a/DT
theoretically/RB
designed/VBN
homology/NN
model/NN
(/(
1xir/CD
)/)
was/VBD
obtained/VBN
from/IN
Protein/NN
Data/NNS
Bank/NN
(/(
PDB/NN
)/)
./.
====================
Homology/NN
modeling/VBG
can/MD
be/VB
described/VBN
in/IN
four/CD
steps/NNS
:/:
(/(
A/DT
)/)
identification/NN
of/IN
a/DT
homolog/NN
from/IN
PDB/NN
whose/WP$
structure/NN
is/VBZ
known/VBN
;/:
(/(
B/NN
)/)
alignment/positioning/VBG
of/IN
our/PRP$
query/RB
sequence/NN
to/TO
the/DT
template/JJ
or/CC
model/NN
sequence/NN
;/:
(/(
C/NN
)/)
construction/NN
of/IN
the/DT
replica/model/NN
based/VBN
on/IN
the/DT
alignment/JJ
;/:
and/CC
(/(
D/NN
)/)
entrance/VBP
and/CC
refinement/JJ
of/IN
the/DT
model/NN
./.
====================
A/DT
sequence/NN
similarity/NN
of/IN
30/CD
%/NN
to/TO
a/DT
known/JJ
protein/NN
structure/NN
being/VBG
often/RB
predicted/VBN
and/CC
is/VBZ
equivalent/JJ
to/TO
a/DT
lowresolution/JJ
Xray/NN
structure/NN
(/(
Xiang/NNP
,/,
2006/CD
)/)
./.
====================
The/DT
3D/NN
coordinates/VBZ
of/IN
the/DT
template/NN
used/VBN
were/VBD
available/JJ
./.
====================
By/IN
using/VBG
Swiss/JJ
Protein/NN
Deep/NN
Viewer/JJR
,/,
various/JJ
structural/JJ
implementations/NNS
were/VBD
carried/VBN
out/RP
from/IN
the/DT
coordinate/JJ
file/JJ
for/IN
the/DT
selected/VBN
amino/NN
acidsAsp66His/NN
,/,
Asn54Lys/NNS
,/,
and/CC
Asp50Asninvolved/JJ
in/IN
obvious/JJ
clinical/JJ
syndromes/NNS
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
Asp66/DT
,/,
Asn54/NN
,/,
and/CC
Asp50/NN
were/VBD
mutated/VBN
to/TO
His66/NN
,/,
Asn54/NN
,/,
and/CC
Asp50/NN
,/,
respectively/RB
,/,
and/CC
a/DT
study/NN
was/VBD
carried/VBN
out/RP
to/TO
observe/VB
changes/NNS
in/IN
hydrogen/NN
bonds/NNS
,/,
bond/CC
lengths/NNS
,/,
angles/NNS
,/,
and/CC
rotations/NNS
./.
====================
Energy/NN
calculations/NNS
for/IN
wildtype/JJ
and/CC
mutated/VBN
amino/NN
acids/NNS
were/VBD
made/VBN
by/IN
using/VBG
the/DT
GROMOSS96/NN
implementation/NN
of/IN
the/DT
Swiss/NN
Protein/NN
Deep/NN
Viewer/JJR
./.
====================
The/DT
PI/NN
values/NNS
of/IN
the/DT
individual/JJ
amino/NN
acid/NN
residues/NNS
,/,
wildtype/JJ
and/CC
mutant/JJ
,/,
were/VBD
compared/VBN
on/IN
the/DT
basis/NN
of/IN
an/DT
available/JJ
table/JJ
(/(
Williams/NNS
et/FW
al./FW
,/,
1987/CD
)/)
./.
====================
In/IN
nature/NN
,/,
a/DT
protein/NN
is/VBZ
stabilized/VBN
by/IN
protein/NN
folds/VBZ
into/IN
one/CD
or/CC
more/RBR
specific/JJ
conformations/NNS
to/TO
perform/VB
biological/JJ
functions/NNS
./.
====================
The/DT
specific/JJ
conformations/NNS
are/VBP
driven/VBN
by/IN
various/JJ
interactions/NNS
,/,
such/JJ
as/IN
hydrogen/NN
bonding/VBG
,/,
bond/NN
angles/NNS
,/,
and/CC
various/JJ
forces/NNS
./.
====================
The/DT
226/CD
amino/NN
acids/NNS
of/IN
connexin/NN
26/CD
are/VBP
known/VBN
./.
====================
The/DT
3D/NN
structure/NN
of/IN
connexin/NN
26/CD
is/VBZ
well/RB
known/VBN
and/CC
was/VBD
obtained/VBN
from/IN
Protein/NN
Data/NNS
Bank/NN
./.
====================
Mutations/NNS
in/IN
the/DT
gap/NN
junction/NN
β2/NN
gene/NN
cause/VBP
a/DT
substitution/NN
of/IN
different/JJ
amino/NN
acids/NNS
of/IN
connexin/NN
26/CD
and/CC
result/NN
in/IN
various/JJ
syndromes/NNS
./.
====================
In/IN
the/DT
present/JJ
work/NN
,/,
3/CD
amino/NN
acids/NNS
of/IN
the/DT
E1/NN
domain/NN
of/IN
the/DT
protein/NN
were/VBD
selected/VBN
to/TO
determine/VB
the/DT
characteristic/JJ
changes/NNS
affecting/VBG
the/DT
physiology/NN
of/IN
connexin/NN
26/CD
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
Asp66His/NN
causes/VBZ
a/DT
hydrogen/NN
bond/NN
breakage/NN
to/TO
Asn62/NN
(/(
Table/JJ
1/CD
)/)
,/,
resulting/VBG
in/IN
a/DT
significant/JJ
increase/NN
in/IN
energy/NN
for/IN
bonds/NNS
(/(
18.494/CD
KJ/mol/NN
for/IN
mutant/JJ
compared/VBN
to/TO
5.516/CD
KJ/mol/NN
for/IN
wildtype/JJ
)/)
./.
====================
The/DT
angular/JJ
energy/NN
increased/VBD
by/IN
2.457/CD
KJ/mol/NN
for/IN
His66/NN
./.
====================
The/DT
CG1CB1/NN
rotation/NN
for/IN
His66/NN
changed/VBD
the/DT
CA1CB1CG1/NN
angle/JJ
from/IN
108.76o/CD
for/IN
the/DT
wildtype/JJ
to/TO
115.05o/JJ
for/IN
the/DT
mutated/VBN
amino/NN
acid/NN
(/(
Table/JJ
2/CD
)/)
./.
====================
The/DT
CG1CB1/NN
bond/NN
rotation/NN
disturbs/NNS
the/DT
existing/VBG
hydrogen/NN
bond/NN
(/(
2.67/CD
Å/NN
)/)
to/TO
Asn62/NN
(/(
Fig/NN
./.
====================
2A/NN
,/,
2B/NN
)/)
./.
====================
The/DT
aromatic/JJ
ring/NN
of/IN
His66/NN
reduces/VBZ
the/DT
distance/NN
to/TO
Pro70/NN
(/(
CD1CB1/NN
distance/NN
,/,
4.98/CD
Å/NN
for/IN
wildtype/JJ
to/TO
CE11CG1/NN
4.06/CD
Å/NN
bond/NN
length/NN
for/IN
the/DT
mutation/NN
)/)
./.
====================
Another/DT
important/JJ
change/NN
observed/VBN
is/VBZ
the/DT
shift/NN
in/IN
normal/JJ
charges/NNS
of/IN
the/DT
residue/NN
from/IN
negative/JJ
to/TO
positive/JJ
,/,
with/IN
the/DT
increase/NN
in/IN
PI/NN
value/NN
from/IN
2.77/CD
to/TO
7.59/CD
./.
====================
But/CC
,/,
the/DT
shift/NN
in/IN
hydrogen/NN
bonding/VBG
is/VBZ
enough/RB
to/TO
play/VB
a/DT
considerable/JJ
role/NN
in/IN
affecting/VBG
the/DT
normal/JJ
interaction/NN
of/IN
protein/NN
residues/NNS
and/CC
,/,
ultimately/RB
,/,
the/DT
overall/JJ
charge/NN
of/IN
ion/NN
channels/NNS
and/CC
their/PRP$
interactions/NNS
with/IN
ions/NNS
and/CC
metabolites/NNS
associated/VBN
with/IN
transportation/NN
functioning/VBG
./.
====================
The/DT
high-molecular-weight/JJ
(/(
114/CD
)/)
polar/JJ
amino/NN
acid/NN
asparagine/NN
affects/VBZ
the/DT
structure/NN
of/IN
proteins/NNS
in/IN
a/DT
highly/RB
specific/JJ
manner/NN
by/IN
providing/VBG
a/DT
strong/JJ
driving/VBG
force/VBP
for/IN
folding/VBG
./.
====================
Moreover/RB
,/,
it/PRP
possesses/VBZ
interesting/JJ
hydrogen/NN
bond/NN
properties/NNS
that/WDT
resemble/JJ
the/DT
backbone/NN
peptides/NNS
./.
====================
A/DT
missense/NN
mutation/NN
,/,
Asn54Lys/NNS
,/,
causes/VBZ
hydrogen/NN
bond/NN
breakage/NN
to/TO
Leu56/NN
(/(
3.12/CD
Å/NN
)/)
and/CC
Thr55/NN
(/(
3.05/CD
Å/NN
)/)
(/(
Fig/NN
./.
====================
2C/NN
,/,
2D/NN
)/)
./.
====================
The/DT
hydrogen/NN
bond/CC
breakage/NN
results/VBZ
in/IN
a/DT
shift/NN
in/IN
tortional/JJ
energy/NN
(/(
4.702/CD
kJ/mol/NN
for/IN
wildtype/JJ
to/TO
7.002/CD
kJ/mol/NN
for/IN
mutant/JJ
)/)
and/CC
a/DT
tremendous/JJ
decrease/NN
in/IN
electrostatic/JJ
potential/JJ
energy/NN
by/IN
37.5/CD
kJ/mol/NN
(/(
52.92/CD
kJ/mol/NN
for/IN
wildtype/JJ
to/TO
15.42/CD
kJ/mol/NN
for/IN
the/DT
mutation/NN
)/)
,/,
along/IN
with/IN
a/DT
decrease/NN
in/IN
energy/NN
for/IN
bonds/NNS
(/(
7.729/CD
kJ/mol/NN
for/IN
wildtype/JJ
to/TO
5.777/CD
for/IN
mutant/JJ
)/)
and/CC
angles/NNS
(/(
1.841/CD
kJ/mol/NN
for/IN
wildtype/JJ
and/CC
1.421/CD
kJ/mol/NN
for/IN
mutant/JJ
)/)
(/(
Table/JJ
1/CD
&/CC
2/CD
)/)
./.
====================
The/DT
additional/JJ
methyl/NN
groups/NNS
(/(
CD1/NN
and/CC
CE1/NN
)/)
of/IN
the/DT
mutant/JJ
Lys54/NN
side/JJ
chain/NN
,/,
compared/VBN
to/TO
the/DT
wild-type/JJ
Asn54/NN
residue/NN
,/,
results/VBZ
in/IN
much/RB
closer/RBR
contact/NN
with/IN
the/DT
adjacent/JJ
Val84/NN
side/JJ
chain/NN
(/(
2.98/CD
Å/NNP
for/IN
mutant/JJ
compared/VBN
to/TO
4.21/CD
Å/NNP
for/IN
wild-type/JJ
)/)
and/CC
forms/VBZ
a/DT
new/JJ
hydrogen/NN
bond/NN
(/(
2.39/CD
Å/NNP
)/)
to/TO
the/DT
carbonyl/JJ
group/NN
of/IN
Ser113/NN
(/(
Fig/NN
./.
====================
2C/NN
,/,
2D/NN
)/)
./.
====================
The/DT
changes/NNS
significantly/RB
decrease/VB
the/DT
electrostatic/JJ
energy/NN
with/IN
a/DT
minimal/JJ
change/NN
in/IN
CA1-CB1-CG1/NN
bond/NN
angle/JJ
(/(
109.53o/CD
to/TO
109.54o/CD
)/)
but/CC
increase/VBP
the/DT
energy/NN
of/IN
the/DT
whole/JJ
protein/NN
considerably/RB
from/IN
6,946.490/CD
kJ/mol/NN
for/IN
wild-type/JJ
to/TO
7,316.498/CD
kJ/mol/NN
for/IN
the/DT
mutated/VBN
protein/NN
(/(
Table/JJ
2/CD
)/)
./.
====================
In/IN
addition/NN
,/,
a/DT
connexin/NN
26/CD
mutation/NN
,/,
Asn54/NN
to/TO
Lys/NNS
,/,
shifts/VBZ
the/DT
interaction/NN
from/IN
114/CD
Glu/NNP
to/TO
the/DT
CA/NN
and/CC
CG/NN
atoms/NNS
of/IN
the/DT
protein/NN
's/POS
polar/JJ
amino/NN
acid/NN
residue/NN
110/CD
Glu/NNP
at/IN
a/DT
cutoff/JJ
score/RB
of/IN
2/CD
with/IN
an/DT
additional/JJ
increase/NN
in/IN
PI/NN
value/NN
from/IN
5.41/CD
for/IN
wild-type/JJ
to/TO
9.47/CD
for/IN
the/DT
mutated/VBN
residue/NN
and/CC
a/DT
charge/JJ
reversal/JJ
from/IN
a/DT
neutral/JJ
to/TO
basic/JJ
residue/JJ
with/IN
a/DT
strong/JJ
positive/JJ
charge/JJ
./.
====================
The/DT
positively/RB
charged/VBN
residue/NN
repels/VBZ
the/DT
positive/JJ
ions/NNS
and/CC
metabolites/NNS
and/CC
thus/RB
impairs/VBZ
trafficking/VBG
through/IN
ion/NN
channels/NNS
of/IN
connexin/NN
proteins/NNS
./.
====================
A/DT
decrease/NN
in/IN
signal/NN
for/IN
the/DT
next/JJ
pathway/NN
causes/VBZ
syndromes/NNS
and/CC
hearing/JJ
impairment/NN
./.
====================
Mutations/NNS
leading/VBG
to/TO
Asp50Asn/NN
apparently/RB
do/VBP
not/RB
affect/VB
peptide/NN
bonds/NNS
or/CC
hydrogen/NN
bonding/VBG
(/(
Fig/NN
./.
====================
2E/DT
,/,
2F/NN
)/)
but/CC
significantly/RB
rotate/VB
the/DT
CA1CB1CG1/NN
bond/NN
angle/JJ
from/IN
105.45o/CD
for/IN
wildtype/JJ
to/TO
111.17o/CD
for/IN
the/DT
mutated/VBN
protein/NN
./.
====================
The/DT
CG1CB1/NN
rotation/NN
cause/VBP
a/DT
tremendous/JJ
decrease/NN
in/IN
energy/NN
for/IN
bonds/NNS
(/(
63.585/CD
kJ/mol/NN
for/IN
wildtype/JJ
to/TO
6.228/CD
kJ/mol/NN
for/IN
mutant/JJ
)/)
,/,
and/CC
electrostatic/JJ
energy/NN
decreases/VBZ
by/IN
3.3/CD
kJ/mol/NN
(/(
11.46/CD
kJ/mol/NN
for/IN
wildtype/JJ
to/TO
8.16k/mol/JJ
for/IN
the/DT
mutant/JJ
)/)
with/IN
an/DT
overall/JJ
decrease/NN
in/IN
the/DT
energy/NN
of/IN
the/DT
protein/NN
from/IN
6946.490/CD
kJ/mol/NN
to/TO
6811.053/CD
kJ/mol/NN
(/(
Table/JJ
2/CD
)/)
./.
====================
In/IN
addition/NN
,/,
the/DT
connexin/NN
26/CD
mutation/NN
Asp50Asn/NN
results/NNS
in/IN
a/DT
considerable/JJ
increase/VBP
in/IN
PI/NN
value/NN
from/IN
2.77/CD
in/IN
the/DT
wildtype/JJ
to/TO
5.41/CD
for/IN
the/DT
mutated/VBN
residue/NN
./.
====================
This/DT
inhibits/VBZ
the/DT
Van/NN
der/NN
Waals/NNS
interaction/NN
of/IN
the/DT
OD1/NN
and/CC
OD2/NN
atoms/NNS
of/IN
the/DT
Asp50/NN
side/JJ
chains/NNS
to/TO
the/DT
backbone/NN
oxygen/NN
atom/IN
of/IN
Glu47/NN
at/IN
a/DT
cutoff/JJ
score/RB
of/IN
2/CD
./.
====================
Alterations/NNS
in/IN
atomic/JJ
interaction/NN
and/CC
a/DT
charge/JJ
reversal/JJ
from/IN
negative/JJ
to/TO
neutral/JJ
result/NN
in/IN
impaired/JJ
trafficking/VBG
of/IN
positive/JJ
ions/NNS
and/CC
metabolites/NNS
,/,
such/JJ
as/IN
calcium/NN
and/CC
potassium/NN
ions/NNS
,/,
with/IN
reduced/VBN
transportation/NN
and/CC
signaling/NN
to/TO
the/DT
next/JJ
pathways/NNS
and/CC
,/,
ultimately/RB
,/,
cell/NN
death/NN
./.
====================
The/DT
long/JJ
arm/NN
of/IN
human/JJ
chromosome/NN
13/CD
holds/NNS
a/DT
very/RB
important/JJ
gene/NN
,/,
GJB2/NN
,/,
related/JJ
to/TO
proper/JJ
hearing/NN
(/(
Castillo/NN
et/FW
al./FW
,/,
2005/CD
)/)
./.
====================
The/DT
gene/NN
GJB2/NN
translates/VBZ
into/IN
the/DT
connexin/NN
protein/NN
,/,
which/WDT
belongs/VBZ
to/TO
the/DT
connexin/NN
family/NN
in/IN
vertebrates/NNS
./.
====================
One/CD
of/IN
the/DT
proteins/NNS
,/,
connexin/NN
26/CD
,/,
transcribed/VBN
by/IN
the/DT
gap/NN
junction/NN
β-2/NN
gene/NN
,/,
belongs/VBZ
to/TO
a/DT
group/NN
of/IN
structurally/RB
similar/JJ
trans-proteins/NNS
that/DT
assemble/JJ
each/DT
other/JJ
and/CC
form/VBP
gap/NN
junctions/NNS
(/(
Soninsky/NNP
,/,
1995/CD
)/)
./.
====================
This/DT
protein/NN
is/VBZ
colocalized/VBN
to/TO
connexin/NN
30/CD
and/CC
permits/VBZ
the/DT
transfer/NN
of/IN
ions/NNS
and/CC
small/JJ
molecules/NNS
in/IN
their/PRP$
adjacent/JJ
cells/NNS
./.
====================
In/IN
such/JJ
a/DT
way/NN
,/,
the/DT
protein/NN
couples/NNS
the/DT
various/JJ
cells/NNS
both/CC
metabolically/RB
and/CC
electrically/RB
and/CC
maintains/VBZ
the/DT
cellular/JJ
homeostasis/NN
(/(
Mahasneh/NN
and/CC
Battah/NN
,/,
2006/CD
)/)
./.
====================
Connexin/NN
26/CD
mutations/NNS
are/VBP
the/DT
cause/NN
of/IN
nonsyndromic/JJ
recessive/JJ
and/CC
dominant/JJ
forms/NNS
of/IN
hearing/JJ
impairment/NN
(/(
Kelsell/NN
et/FW
al./FW
,/,
1997/CD
)/)
./.
====================
A/DT
point/NN
mutation/NN
at/IN
nucleotide/NN
162/CD
in/IN
codon/NN
54/CD
changes/NNS
C/NN
to/TO
A/DT
./.
====================
This/DT
substitution/NN
leads/VBZ
to/TO
the/DT
replacement/JJ
of/IN
the/DT
evolutionarily/RB
conserved/VBN
asparagine/NN
54/CD
to/TO
an/DT
electronegatively/RB
charged/VBN
lysine/NN
in/IN
the/DT
first/JJ
expended/VBD
loop/NN
of/IN
connexin/NN
26/CD
(/(
Richard/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
The/DT
resultant/JJ
mutation/NN
destroys/VBZ
the/DT
hydrogen/NN
bond/NN
from/IN
the/DT
amide/NN
group/NN
of/IN
Leu56/NN
(/(
Fig/NN
./.
====================
2D/CD
)/)
./.
====================
Additional/JJ
methyl/NN
groups/NNS
of/IN
Leu54/NN
extend/VBP
to/TO
Ser113/NN
,/,
and/CC
the/DT
carbonyl/JJ
group/NN
of/IN
Ser113/NN
shares/VBZ
a/DT
hydrogen/NN
bond/NN
with/IN
the/DT
Lys54/NN
amide/NN
group/NN
(/(
Fig/NN
./.
====================
2D/CD
)/)
./.
====================
Such/JJ
subtle/JJ
changes/NNS
alter/VBP
the/DT
energy/NN
of/IN
the/DT
whole/JJ
protein/NN
from/IN
6946.490/CD
kJ/mol/NN
to/TO
7316.498/CD
kJ/mol/NN
(/(
Table/JJ
2/CD
)/)
./.
====================
These/DT
changes/NNS
might/MD
be/VB
involved/VBN
in/IN
reducing/VBG
the/DT
expression/NN
of/IN
connexin/NN
26/CD
,/,
causing/VBG
Kunckle/JJ
pads/VBZ
and/CC
leukonychia/NN
(/(
Bart/NN
et/FW
al./FW
,/,
1967/CD
)/)
./.
====================
Affected/JJ
family/NN
members/NNS
suffer/VBP
from/IN
thickened/JJ
skin/NN
of/IN
the/DT
palms/NNS
and/CC
soles/NNS
in/IN
early/JJ
childhood/NN
(/(
Richard/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
The/DT
mutation/NN
Asn54Lys/NNS
disturbs/NNS
the/DT
hydrogen/NN
bonds/NNS
and/CC
seems/VBZ
to/TO
be/VB
a/DT
contributing/VBG
factor/NN
toward/IN
reduced/VBD
epidermal/JJ
expression/NN
of/IN
connexin/NN
26/CD
,/,
also/RB
involved/VBN
in/IN
BartPumphrey/NNP
Syndrome/NN
(/(
Richard/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
The/DT
dominant/JJ
point/NN
mutation/NN
of/IN
gap/NN
junction/NN
β2/NN
,/,
causing/VBG
Asp50Asn/NN
,/,
significantly/RB
reduces/VBZ
the/DT
energy/NN
for/IN
bonds/NNS
(/(
63.585/CD
kJ/mol/NN
for/IN
wild-type/JJ
to/TO
6.228/CD
kJ/mol/NN
for/IN
mutant/JJ
)/)
./.
====================
The/DT
CB1-CG1/NN
bond/NN
rotation/NN
affects/VBZ
the/DT
angle/JJ
(/(
105.45o/CD
for/IN
wild-type/JJ
to/TO
111.17o/JJ
for/IN
mutant/JJ
)/)
and/CC
the/DT
decrease/NN
in/IN
the/DT
force/NN
field/NN
energy/NN
of/IN
the/DT
protein/NN
from/IN
6946.490/CD
kJ/mol/NN
to/TO
6811.053/CD
kJ/mol/NN
(/(
Table/JJ
2/CD
)/)
./.
====================
The/DT
substitution/NN
of/IN
the/DT
conserved/VBN
residue/NN
aspartic/JJ
acid/NN
50/CD
by/IN
asparagine/NN
(/(
Asp50Asn/NN
)/)
in/IN
the/DT
first/JJ
extracellular/JJ
domain/NN
of/IN
connexin/NN
26/CD
causes/VBZ
Keratitis-IchthyosisDeafness/NN
Syndrome/NN
(/(
Yotsumoto/NN
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
This/DT
mutation/NN
is/VBZ
likely/JJ
to/TO
be/VB
the/DT
factor/NN
that/WDT
disturbs/VBZ
the/DT
communication/NN
of/IN
ions/NNS
,/,
metabolites/NNS
,/,
and/CC
signaling/NN
molecules/NNS
in/IN
neighboring/JJ
cells/NNS
and/CC
affects/VBZ
homeostasis/NN
by/IN
disturbing/VBG
the/DT
bonding/JJ
and/CC
energies/VBZ
(/(
Saez/NNP
et/FW
al./FW
,/,
2000/CD
)/)
./.
====================
Charge/JJ
reversal/JJ
and/CC
the/DT
reduced/VBN
distance/NN
of/IN
His66/NN
to/TO
Pro70/NN
due/JJ
to/TO
Asp66His/NN
alter/VBP
the/DT
normal/JJ
protein/NN
bonding/VBG
(/(
Fig/NN
./.
====================
2B/NN
)/)
,/,
causing/VBG
Vohwinkel/NN
syndrome/NN
(/(
Snoeckx/NN
et/FW
al./FW
,/,
2005/CD
)/)
./.
====================
This/DT
might/MD
result/VB
in/IN
impaired/JJ
trafficking/VBG
of/IN
connexin/NN
26/CD
,/,
its/PRP$
assembly/NN
with/IN
other/JJ
proteins/NNS
,/,
and/CC
docking/NN
with/IN
adjacent/JJ
cells/NNS
(/(
Maestrini/NNS
,/,
et/FW
al./FW
,/,
1999/CD
;/:
Marziano/NNP
,/,
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
Normally/RB
,/,
connexin/NN
assembles/NNS
at/IN
the/DT
planer/NN
of/IN
the/DT
plasma/NN
membrane/NN
involved/VBN
in/IN
the/DT
formation/NN
of/IN
the/DT
gap/NN
junction/NN
plaque/NN
./.
====================
Asp66His/NN
enlarges/VBZ
the/DT
CA1CB1/NN
CG1/NN
angle/JJ
from/IN
108.76o/CD
to/TO
115.05o/CD
./.
====================
Such/JJ
factors/NNS
might/MD
be/VB
involved/VBN
in/IN
contributing/VBG
to/TO
the/DT
plane/NN
of/IN
connexin/NN
26/CD
,/,
disturbing/VBG
the/DT
members/NNS
of/IN
the/DT
whole/JJ
connexin/NN
unit/NN
,/,
which/WDT
ultimately/RB
affects/VBZ
membranous/JJ
communication/NN
and/CC
results/VBZ
in/IN
hearing/JJ
loss/NN
and/CC
skin/NN
diseases/NNS
./.
====================
Connexin/NN
26/CD
is/VBZ
an/DT
important/JJ
protein/NN
involved/VBN
in/IN
normal/JJ
hearing/JJ
./.
====================
Mutations/NNS
affect/VB
the/DT
protein/NN
's/POS
function/NN
by/IN
disturbing/VBG
the/DT
associated/VBN
factors/NNS
./.
====================
However/RB
,/,
similar/JJ
to/TO
various/JJ
other/JJ
proteins/NNS
,/,
normal/JJ
functioning/VBG
of/IN
connexin/NN
26/CD
is/VBZ
associated/VBN
with/IN
a/DT
range/NN
of/IN
factors/NNS
./.
====================
Hydrogen/NN
bonding/VBG
,/,
residual/JJ
energies/VBZ
,/,
atomic/JJ
angles/NNS
,/,
and/CC
residual/JJ
charges/NNS
are/VBP
the/DT
main/JJ
contributing/VBG
factors/NNS
that/WDT
affect/VBP
ion/NN
channels/NNS
and/CC
their/PRP$
transportation/NN
./.
====================
This/DT
significant/JJ
increase/NN
in/IN
PI/NN
value/NN
is/VBZ
an/DT
additional/JJ
cause/VBP
of/IN
charge/JJ
reversal/JJ
of/IN
amino/NN
acid/NN
residues/NNS
,/,
which/WDT
repels/VBZ
ions/NNS
and/CC
metabolites/NNS
and/CC
their/PRP$
passage/NN
through/IN
ion/NN
channels/NNS
,/,
inhibiting/VBG
the/DT
next/JJ
signaling/NN
pathway/NN
and/CC
causing/VBG
syndromes/NNS
./.
====================
So/RB
,/,
this/DT
study/NN
could/MD
be/VB
used/VBN
as/IN
a/DT
reference/NN
for/IN
establishing/VBG
a/DT
mechanism/NN
that/WDT
could/MD
inhibit/VB
the/DT
repletion/NN
of/IN
ions/NNS
and/CC
metabolites/NNS
but/CC
push/VBP
them/PRP
back/RB
on/IN
their/PRP$
normal/JJ
track/JJ
./.
====================
